Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C

Telaprevir (TVR) is used for the treatment of chronic hepatitis C in a combination therapy with pegylated-interferon and ribavirin. Although renal dysfunction is one of the critical adverse outcomes of this treatment, little is known regarding the mechanism of its onset. The present study assessed t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Exp Ther Med
Autores principales: KOHJIMA, MOTOYUKI, KUROKAWA, MIHO, ENJOJI, MUNECHIKA, YOSHIMOTO, TSUYOSHI, NAKAMURA, TSUKASA, OHASHI, TOMOKO, FUKUIZUMI, KUNITAKA, HARADA, NAOHIKO, MURATA, YUSUKE, MATSUNAGA, KAZUHISA, KATO, MASAKI, KOTOH, KAZUHIRO, NAKAMUTA, MAKOTO
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840744/
https://ncbi.nlm.nih.gov/pubmed/27168803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3133
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares